ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, etc. The company’s product portfolio includes Fosfomycin tromethamine powder, Ebastine tablets, Tamsulosin hydrochloride sustained release capsules, Cinacalcet hydrochloride tablets, Apixaban tablets, Rivaroxaban tablets, Fluoxetine hydrochloride capsules, Ambroxol hydrochloride dispersible tablets, Montmorillonite powder, Varenicline tartrate tablets, Vitamin AD drops, and Baoling Yunbao oral liquid, as well as salt acid glucosamine raw material product. It also provides medical and health services and commercial services, such as medical diagnosis, gene preservation, and pregnancy environment testing services. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to ShanXi C&Y Pharmaceutical Group Co.,LTD. in September 2014. The company was founded in 2005 and is based in Datong, China.
तुलना करने के लिए मीट्रिक्स | 300254 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध300254पीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 53.3x | 24.1x | −0.5x | |
PEG अनुपात | 0.80 | 0.03 | 0.00 | |
क़ीमत/बुक | 6.6x | 2.7x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 2.7x | 3.2x | 2.9x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 32.4% | 53.4% | |
उचित मूल्य अपसाइड | अनलॉक करें | 1.6% | 10.2% | अनलॉक करें |